Mifepristone

A policy aide, not a regulator: what Overton's FDA nomination changes for sponsors

Heidi Overton would arrive at the FDA from the White House Domestic Policy Council, with a political record rather than a regulatory one. Plan submissions for priorities set from outside the building.